Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma. [electronic resource]
Producer: 20090817Description: 349-56 p. digitalISSN:- 1029-2403
- Adenine Nucleotides -- administration & dosage
- Aged
- Arabinonucleosides -- administration & dosage
- Clofarabine
- Female
- Hematopoiesis
- Humans
- Kinetics
- Lymphoma, Large B-Cell, Diffuse -- complications
- Lymphoma, Mantle-Cell -- complications
- Lymphoma, Non-Hodgkin -- complications
- Male
- Middle Aged
- Myeloablative Agonists -- administration & dosage
- Neutropenia -- chemically induced
- Remission Induction
- Salvage Therapy -- methods
- Survival Analysis
- Thrombocytopenia -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.